|
MONTREAL, QUEBEC--(Marketwired - Feb. 22, 2017) - Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide the following update to its press release of December 22, 2016 announcing a binding letter of intent (the "LOI") to acquire the assets of BioGanix Limited ("BGL"), a privately-held nutraceutical company in Houston, Texas focused on heart, brain, digestive health and joint support products sold through primarily through e-commerce platforms. |
